AR022470A1 - Uso de pirazol-carboxamidas - Google Patents
Uso de pirazol-carboxamidasInfo
- Publication number
- AR022470A1 AR022470A1 ARP000100428A ARP000100428A AR022470A1 AR 022470 A1 AR022470 A1 AR 022470A1 AR P000100428 A ARP000100428 A AR P000100428A AR P000100428 A ARP000100428 A AR P000100428A AR 022470 A1 AR022470 A1 AR 022470A1
- Authority
- AR
- Argentina
- Prior art keywords
- carboxamids
- pirazol
- pyrazolcarboxamides
- novel
- pyrazolecarboxamides
- Prior art date
Links
- BNYCHCAYYYRJSH-UHFFFAOYSA-N 1h-pyrazole-5-carboxamide Chemical class NC(=O)C1=CC=NN1 BNYCHCAYYYRJSH-UHFFFAOYSA-N 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 208000007502 anemia Diseases 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19904397A DE19904397A1 (de) | 1999-02-04 | 1999-02-04 | Verwendung von Pyrazol-Carbonsäureamiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR022470A1 true AR022470A1 (es) | 2002-09-04 |
Family
ID=7896339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000100428A AR022470A1 (es) | 1999-02-04 | 2000-02-01 | Uso de pirazol-carboxamidas |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1148879A2 (fr) |
| JP (1) | JP2002536348A (fr) |
| AR (1) | AR022470A1 (fr) |
| AU (1) | AU3150300A (fr) |
| CA (1) | CA2361636A1 (fr) |
| DE (1) | DE19904397A1 (fr) |
| GT (1) | GT200000009A (fr) |
| WO (1) | WO2000045894A2 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6878729B2 (en) * | 2001-05-04 | 2005-04-12 | The Procter & Gamble Company | Medicinal uses of dihydropyrazoles |
| US8710038B2 (en) | 2004-09-17 | 2014-04-29 | Exelixis, Inc. | Pyrazole kinase modulators and methods of use |
| UY30892A1 (es) | 2007-02-07 | 2008-09-02 | Smithkline Beckman Corp | Inhibidores de la actividad akt |
| CA2750565C (fr) | 2009-01-30 | 2015-10-20 | Glaxosmithkline Llc | Chlorhydrate de n-{(1-s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide cristallin |
| EP4173485A1 (fr) * | 2021-10-27 | 2023-05-03 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Composés inhibant l'agrégation de protéine pour la lutte contre les maladies des plantes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH27357A (en) * | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
| US5434178A (en) * | 1993-11-30 | 1995-07-18 | G.D. Searle & Co. | 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation |
| AU7564296A (en) * | 1995-11-17 | 1997-06-11 | Ciba-Geigy Ag | Solid phase synthesis of heterocyclic compounds and combinatorial compound library |
| DE19904396A1 (de) * | 1999-02-04 | 2000-08-10 | Bayer Ag | Substituierte Pyrazolbenzylamin-Derivate |
| DE19904406A1 (de) * | 1999-02-04 | 2000-08-10 | Bayer Ag | Substituierte Pyrazolcarbonsäuren |
-
1999
- 1999-02-04 DE DE19904397A patent/DE19904397A1/de not_active Withdrawn
-
2000
- 2000-01-24 EP EP00909096A patent/EP1148879A2/fr not_active Withdrawn
- 2000-01-24 JP JP2000597013A patent/JP2002536348A/ja active Pending
- 2000-01-24 WO PCT/EP2000/000519 patent/WO2000045894A2/fr not_active Ceased
- 2000-01-24 CA CA002361636A patent/CA2361636A1/fr not_active Abandoned
- 2000-01-24 AU AU31503/00A patent/AU3150300A/en not_active Abandoned
- 2000-02-01 AR ARP000100428A patent/AR022470A1/es unknown
- 2000-02-03 GT GT200000009A patent/GT200000009A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3150300A (en) | 2000-08-25 |
| EP1148879A2 (fr) | 2001-10-31 |
| GT200000009A (es) | 2001-07-27 |
| CA2361636A1 (fr) | 2000-08-10 |
| JP2002536348A (ja) | 2002-10-29 |
| WO2000045894A2 (fr) | 2000-08-10 |
| WO2000045894A3 (fr) | 2001-04-19 |
| DE19904397A1 (de) | 2000-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0001899D0 (sv) | New compounds | |
| BR0113234A (pt) | Polimorfos de um análogo de epotilona | |
| BR0017026A (pt) | Lipeptìdeos como agentes antibacterianos | |
| BR0108677A (pt) | Novos compostos | |
| BR0208338A (pt) | Derivados de piridina | |
| BR0112589A (pt) | Derivados de heteroarila e sua aplicação como medicamento | |
| BR0211801A (pt) | Derivados de 7h-pirrolo[2,3-d]pirimidina | |
| BR0214469A (pt) | 17alfa-alquil-17beta-óxi-estratrienos e produtos intermediários para sua preparação, aplicação dos 17alfa-alquil-17beta-óxi-estratrienos para a preparação de medicamentos bem como preparações farmacêuticas | |
| MEP39108A (en) | Pharmaceutical composition | |
| BRPI0409136A (pt) | composto heteroaromático pentacìclico e uso medicinal do mesmo | |
| UY27368A1 (es) | Nuevos compuestos | |
| BRPI0414948A (pt) | derivados de pirazolo-e-imidazo pirimidina | |
| BR0017028A (pt) | Lipopepìdeos como agentes antibacterianos | |
| BR0016467A (pt) | Lipopeptìdeos como agentes antibacterianos | |
| BR0111358A (pt) | Compostos de tioacetamida e seu uso | |
| AR022469A1 (es) | Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias | |
| BR0209129A (pt) | Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos | |
| BR0208887A (pt) | Derivados de dihidro-benzo[b][1,4]diazepin-2-ona como antagonistas i de mglur2 | |
| BR9910573A (pt) | Compostos antipicornavirais, preparação e uso dos mesmos | |
| BR0015147A (pt) | Ciclopropanos como cgrp-antagonistas, medicamentos contendo os ditos compostos e processo para a produção dos mesmos | |
| BR9916680A (pt) | Derivados da 3,3-biarilpiperidina e2,2-biarilmorfolina | |
| BRPI0513287A (pt) | derivados de pirido-pirimidina, sua preparação, sua aplicação em terapêutica | |
| BR0114380A (pt) | Derivados-1-aminobutan-3-ol-substituìdos | |
| BR0014233A (pt) | Conjugados de 4-benzilaminoquinolina com ácido galênico e seus heteroanálogos, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação | |
| BRPI0412928A (pt) | dibenzo[b,f]oxepina-10-carboxamidas e usos farmacêuticos das mesmas |